Paul Denslow

Paul Denslow is the CEO and Co-Founder of Intus Bio, the company behind GutID—the first true microbiome test. Paul began his career in finance where he developed a deep understanding of the power of data and platforms, but was drawn to healthcare by a desire to change the paradigm that powerful scientific discoveries frequently make little impact on healthcare - an issue especially acute in the microbiome.  

The microbiome is often described as the biggest untapped opportunity in healthcare and though its connection to a wide range of health outcomes is well established, it remains outside of routine healthcare. Paul co-founded Intus Bio to change that by combining unique next-generation sequencing technology and AI to make the microbiome as central to healthcare, as it is to our health

Paul and Intus Bio share a bold but simple mission: test everybody, every year, for every disease. Through the harnessing of the microbiome’s significant influence on health and the power of Intus Bio’s technology, earlier detection and prevention of many diseases will be possible.